Abstract

Small molecule chemotherapeutics often have undesired physiochemical and pharmacological properties, such as low solubility, severe side effect and narrow therapeutic index. To address these challenges, polymeric nanomedicine drug delivery technology has been routinely employed, in particular with the use of biodegradable and biocompatible polyesters, such as poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA). Here we review the development and use of PLA and PLGA for the delivery of chemotherapeutic agents in the forms of polymer-drug conjugates and nanoconjugates.

Original languageEnglish (US)
Pages (from-to)323-332
Number of pages10
JournalCurrent Opinion in Solid State and Materials Science
Volume16
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Nanoconjugates
Medical nanotechnology
Polyglactin 910
Drug delivery
Polyesters
Solubility
Molecules
Polymers
Pharmaceutical Preparations
polylactic acid-polyglycolic acid copolymer
poly(lactide)

Keywords

  • Cancer
  • Chemotherapeutics
  • Drug delivery
  • Nanoconjugates
  • Nanomedicine
  • PLA
  • PLGA
  • Polymer-drug conjugates

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Polymeric nanomedicines based on poly(lactide) and poly(lactide-co- glycolide). / Tong, Rong; Gabrielson, Nathan P.; Fan, Timothy M; Cheng, Jianjun.

In: Current Opinion in Solid State and Materials Science, Vol. 16, No. 6, 12.2012, p. 323-332.

Research output: Contribution to journalReview article

@article{b5d64929dfc44f91a49a04bec7548831,
title = "Polymeric nanomedicines based on poly(lactide) and poly(lactide-co- glycolide)",
abstract = "Small molecule chemotherapeutics often have undesired physiochemical and pharmacological properties, such as low solubility, severe side effect and narrow therapeutic index. To address these challenges, polymeric nanomedicine drug delivery technology has been routinely employed, in particular with the use of biodegradable and biocompatible polyesters, such as poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA). Here we review the development and use of PLA and PLGA for the delivery of chemotherapeutic agents in the forms of polymer-drug conjugates and nanoconjugates.",
keywords = "Cancer, Chemotherapeutics, Drug delivery, Nanoconjugates, Nanomedicine, PLA, PLGA, Polymer-drug conjugates",
author = "Rong Tong and Gabrielson, {Nathan P.} and Fan, {Timothy M} and Jianjun Cheng",
year = "2012",
month = "12",
doi = "10.1016/j.cossms.2013.01.001",
language = "English (US)",
volume = "16",
pages = "323--332",
journal = "Current Opinion in Solid State and Materials Science",
issn = "1359-0286",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Polymeric nanomedicines based on poly(lactide) and poly(lactide-co- glycolide)

AU - Tong, Rong

AU - Gabrielson, Nathan P.

AU - Fan, Timothy M

AU - Cheng, Jianjun

PY - 2012/12

Y1 - 2012/12

N2 - Small molecule chemotherapeutics often have undesired physiochemical and pharmacological properties, such as low solubility, severe side effect and narrow therapeutic index. To address these challenges, polymeric nanomedicine drug delivery technology has been routinely employed, in particular with the use of biodegradable and biocompatible polyesters, such as poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA). Here we review the development and use of PLA and PLGA for the delivery of chemotherapeutic agents in the forms of polymer-drug conjugates and nanoconjugates.

AB - Small molecule chemotherapeutics often have undesired physiochemical and pharmacological properties, such as low solubility, severe side effect and narrow therapeutic index. To address these challenges, polymeric nanomedicine drug delivery technology has been routinely employed, in particular with the use of biodegradable and biocompatible polyesters, such as poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA). Here we review the development and use of PLA and PLGA for the delivery of chemotherapeutic agents in the forms of polymer-drug conjugates and nanoconjugates.

KW - Cancer

KW - Chemotherapeutics

KW - Drug delivery

KW - Nanoconjugates

KW - Nanomedicine

KW - PLA

KW - PLGA

KW - Polymer-drug conjugates

UR - http://www.scopus.com/inward/record.url?scp=84875244451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875244451&partnerID=8YFLogxK

U2 - 10.1016/j.cossms.2013.01.001

DO - 10.1016/j.cossms.2013.01.001

M3 - Review article

AN - SCOPUS:84875244451

VL - 16

SP - 323

EP - 332

JO - Current Opinion in Solid State and Materials Science

JF - Current Opinion in Solid State and Materials Science

SN - 1359-0286

IS - 6

ER -